Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KEMPER CorpKMPR · Entity 719 | Director | August 10, 2026 | August 11, 2026 |
| Teladoc Health, Inc.TDOC · Entity 1547 | Director · CHIEF EXECUTIVE OFFICER | March 19, 2024 | March 20, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KEMPER Corp
Report date August 10, 2026 · Filed August 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,802 |
Reported balance
After 2026-08-10 transaction · row 1
1 source rowRow 1 · 2026-08-10 · Purchase · Acquired 5,000 · Balance 31,802 |
Teladoc Health, Inc.
Report date March 19, 2024 · Filed March 20, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 197,728 |
Reported balance
After 2024-03-19 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-03-19 · Grant · Acquired 197,728 · Balance 197,728 F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
F2: One-third of the restricted stock units vest on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments beginning on June 1, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 06, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 6,602 | $32.88 | $217,073.76 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F3 · price: Represents the weighted average price of transactions ranging from $32.80 to $33.00. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 06, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 6,602 | $1.07 | $7,064.14 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 824,863 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 13,389 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 196,638 Underlying: Common Stock · 13,389 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 13,389 | $32.89 | $440,364.21 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $32.80 to $33.13. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 05, 2017 Filed Jun 7, 2017 23:23 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 13,389 | $1.07 | $14,326.23 |
DisclosureSEC source: 0001179110-17-008717 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 831,650 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantRestricted Stock Units · Derivative | 50,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-008197 · edgar.xml · derivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. F5 · derivative.exercise_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. F5 · derivative.expiration_date: The restricted stock unit vests in four equal annual installments beginning March 3, 2018. Read SEC document |
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 5,600 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-008197 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,027 Underlying: Common Stock · 5,600 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 5,600 | $29.57 | $165,592.00 |
DisclosureSEC source: 0001179110-17-008197 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $29.55 to $29.60. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 25, 2017 Filed May 30, 2017 21:29 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 5,600 | $1.07 | $5,992.00 |
DisclosureSEC source: 0001179110-17-008197 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 823,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 9,700 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · derivative · entry 6 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,627 Underlying: Common Stock · 9,700 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 9,700 | $29.56 | $286,732.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F3 · price: Represents the weighted average price of transactions ranging from $29.55 to $29.63. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 23, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 9,700 | $1.07 | $10,379.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,700 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · derivative · entry 5 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,327 Underlying: Common Stock · 4,700 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The options vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 4,700 | $29.58 | $139,026.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F2 · price: Represents the weighted average price of transactions ranging from $29.55 to $29.70. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 22, 2017 Filed May 24, 2017 20:51 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 4,700 | $1.07 | $5,029.00 |
DisclosureSEC source: 0001179110-17-007917 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 822,961 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2017 Filed May 10, 2017 22:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $1.07 | $0.00 |
DisclosureSEC source: 0001179110-17-007022 · edgar.xml · derivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,027 Underlying: Common Stock · 15,000 shares Expires 2022-04-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested as to 25% of the shares on April 16, 2013 and became fully vested on April 16, 2016. Read SEC document |
| May 08, 2017 Filed May 10, 2017 22:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 15,000 | $23.11 | $346,650.00 |
DisclosureSEC source: 0001179110-17-007022 · edgar.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 17, 2017. F1 · price: Represents the weighted average price of transactions ranging from $23.10 to $23.18. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| May 08, 2017 Filed May 10, 2017 22:56 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | Exercise / conversionCommon Stock | 15,000 | $1.07 | $16,050.00 |
DisclosureSEC source: 0001179110-17-007022 · edgar.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 833,261 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 03, 2017 Filed Mar 7, 2017 23:40 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GrantEmployee Stock Option · Derivative | 404,600 | $0.00 Strike: $22.30 | $0.00 |
DisclosureSEC source: 0001179110-17-004165 · edgar.xml · derivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 404,600 Underlying: Common Stock · 404,600 shares Expires 2027-03-03 F1 · derivative.exercise_date: The option will vest as to 25% of the shares on March 3, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter. Read SEC document |
| January 24, 2017 Filed Jan 26, 2017 22:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | SaleCommon Stock | 100,000 | $15.79 | $1,579,000.00 |
DisclosureSEC source: 0001104659-17-004341 · a4.xml · nonDerivative · entry 4 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818,261 Read SEC document |
| December 06, 2016 Filed Jan 26, 2017 22:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 1,627 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-004341 · a4.xml · nonDerivative · entry 3 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 918,261 Read SEC document |
| November 03, 2016 Filed Jan 26, 2017 22:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 6,270 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-004341 · a4.xml · nonDerivative · entry 2 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 919,888 Read SEC document |
| October 25, 2016 Filed Jan 26, 2017 22:01 UTC | Teladoc Health, Inc. TDOC · Entity 1547 | GiftCommon Stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-17-004341 · a4.xml · nonDerivative · entry 1 GOREVIC JASON N · CIK 0001208500 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 926,158 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.